Understanding Frontotemporal Dementia in Rhesus Macaques

Modeling Frontotemporal Dementia in Rhesus Macaques

NIH-funded research University of Wisconsin-Madison · NIH-10845480

This study is looking at how frontotemporal dementia affects monkeys with a gene linked to the disease, so researchers can learn more about memory loss and personality changes to help find better treatments for people with FTD.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison NIH-funded
Lab location1 site (Madison, United States)
Project IDNIH-10845480 on NIH RePORTER

What this research studies

This research investigates frontotemporal dementia (FTD) in rhesus macaques that carry a specific genetic mutation linked to the disease. By studying these monkeys, researchers aim to better understand the progression of memory loss, personality changes, and other symptoms associated with FTD. The approach includes behavioral tests, MRI scans, and PET imaging to observe brain changes and tau accumulation, which are crucial for developing effective treatments. This work could provide insights into the disease that are directly applicable to human patients.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with a family history of frontotemporal dementia or those diagnosed with the MAPT R406W mutation.

Not a fit: Patients with other forms of dementia that do not involve the MAPT gene mutation may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients suffering from frontotemporal dementia and related disorders.

How similar studies have performed: Previous research has shown success in using nonhuman primates to model neurodegenerative diseases, indicating that this approach has potential for yielding valuable insights.

Where this research is happening

Madison, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.